Key Highlights

  • Oura is expected to price its IPO around September 30, according to Segmara's IPO calendar.
  • On Monday, the S&P 500 fell 59.72 points to 7,683.69 and the Nasdaq Composite dropped 248.34 points to 26,820.38.
  • Pricing at the top of the $40 to $44 range, or above it, would suggest strong demand.
  • The Federal Reserve raised rates in September, and futures price a majority chance of another hike in October.

Smart-ring maker Oura is set to price its initial public offering around Wednesday, September 30, and its size and consumer-tech profile make it the week's marquee listing, even as yields climb and stocks wobble.

The deal on the table

Oura is expected to price its IPO around September 30, according to Segmara's IPO calendar. The company plans to sell 50 million shares at $40 to $44 each under the ticker OURA, and Segmara puts the deal at about $2.53 billion. That makes it far larger than Accelevation's planned offering, and SIYATA PTT is also on this week's calendar.

No IPO debuted on Monday, September 28, according to Segmara, which puts extra focus on the handful of deals lined up for the end of the quarter.

Why it stands out

Oura is best known for its smart ring, a wearable that tracks sleep, activity and other health signals. That gives it something rare on the IPO calendar: a product that ordinary consumers recognize. Well-known consumer brands often draw heavy retail interest when they list, which can amplify first-day moves in either direction.

Its size matters too. A deal of this scale is a real test of investor appetite. A strong reception would signal that the window for new listings remains open despite the market's recent turbulence. A weak one would suggest buyers are becoming more selective.

Wearable health devices are a competitive field, so investors will inevitably compare Oura with larger consumer-electronics players. The final pricing and the first days of trading will be the market's first chance to judge how it values a company built around a distinctive wearable.

A tricky market to launch into

The timing is not easy. On Monday, the S&P 500 fell 59.72 points to 7,683.69 and the Nasdaq Composite dropped 248.34 points to 26,820.38. The 10-year Treasury Yield hit its highest level since 2007, and the VIX, Wall Street's fear gauge, rose 1.20 points to 16.07. Higher yields tend to weigh on growth companies because they reduce the present value of future profits.

The Federal Reserve raised rates in September, and futures price a majority chance of another hike in October. Oil rose after President Trump rejected Iran's plan to reopen the Strait of Hormuz, and chip stocks slid on reports that OpenAI paused Training of some frontier models.

How recent IPOs have fared

ADARx Pharmaceuticals, which listed on September 25 at $17, was trading around $19.35. American Savings Bank, priced at $16 on September 16, was near $18.30. But Electra Therapeutics, priced at $15 on September 18, had fallen to about $11.55, and Orion180 Insurance, priced at $12, was around $9.57.

That split shows that investors are rewarding some new issues and punishing others. It also means where Oura prices within, above or below its range will be read as a signal for the wider IPO market.

The final price and first-day trading are the signals

The key signals are the final price and the first day of trading. Pricing at the top of the $40 to $44 range, or above it, would suggest strong demand. Pricing at the low end, or a smaller deal, would point to caution.

The macro backdrop could shape that reception. Oura is expected to price on the same day as August PCE inflation, quarter-end and Micron (NASDAQ:MU)'s earnings, and its first trading days fall around the ISM Manufacturing survey on Thursday and the September jobs report on Friday. A calmer Bond Market would help; another leg higher in yields could make the debut far more volatile.